Department of Psychological Science, University of Vermont, John Dewey Hall, 2 Colchester Avenue, Burlington, VT 05401, United States.
Department of Psychological Science, University of Vermont, John Dewey Hall, 2 Colchester Avenue, Burlington, VT 05401, United States.
J Affect Disord. 2022 Jan 1;296:9-16. doi: 10.1016/j.jad.2021.08.154. Epub 2021 Sep 25.
Efficacious treatments for winter seasonal affective disorder (SAD) include light therapy (LT) and cognitive-behavioral therapy (CBT-SAD); however, baseline characteristics may differentially predict treatment outcomes. This study investigated body mass index (BMI) and atypical balance (the proportion of atypical depression symptoms), as predictors of depression remission.
The parent study randomized 177 adults diagnosed with Major Depression, Recurrent with Seasonal Pattern to 6-weeks of CBT-SAD (n = 88) or LT (n = 89) and followed participants one and two winters later. At baseline, BMI was measured and atypical balance was derived using the Structured Interview Guide for the Hamilton Rating Scale for Depression-Seasonal Affective Disorder Version (SIGH-SAD) as 8-item atypical subscale score/total SIGH-SAD score × 100. Depression remission was defined using standard SIGH-SAD cutpoints. Hierarchical logistic regressions tested the main effects of treatment modality, BMI, and atypical balance and their interactive effects on depression remission at post-treatment and follow-ups.
The BMI × treatment and atypical balance × treatment interactions significantly predicted depression remission at second winter follow-up. The probability of remission was higher in CBT-SAD than LT at BMI ≤ 26.1 and atypical balance ≤ 40.3%. This predictive relationship survived when adjusting atypical balance for BMI, but not vice-versa.
Participants were predominantly White and older. BMI does not account for muscle mass or fat distribution.
BMI and atypical balance prescriptively predicted higher likelihood of depression remission two winters following CBT-SAD but not LT. This work informs clinical decision-making and precision medicine efforts.
冬季季节性情感障碍(SAD)的有效治疗方法包括光疗(LT)和认知行为疗法(CBT-SAD);然而,基线特征可能会对治疗结果产生不同的预测。本研究调查了体重指数(BMI)和非典型平衡(非典型抑郁症状的比例)作为抑郁缓解的预测指标。
该研究的母项随机将 177 名被诊断为复发性伴有季节性模式的重度抑郁症患者分为 6 周的 CBT-SAD(n=88)或 LT(n=89)组,并在随后的两个冬季对参与者进行随访。在基线时,测量 BMI,并使用 Hamilton 抑郁量表季节性情感障碍版(SIGH-SAD)的结构访谈指南作为 8 项非典型亚量表评分/总 SIGH-SAD 评分×100,得出非典型平衡。使用标准 SIGH-SAD 切点定义抑郁缓解。分层逻辑回归测试了治疗方式、BMI 和非典型平衡的主要效应及其对治疗后和随访时抑郁缓解的交互效应。
BMI×治疗和非典型平衡×治疗的交互作用显著预测了第二个冬季随访时的抑郁缓解。在 BMI≤26.1 和非典型平衡≤40.3%时,CBT-SAD 的缓解率高于 LT。当调整 BMI 时,这种预测关系仍然存在,但反之则不然。
参与者主要是白人和老年人。BMI 不能反映肌肉质量或脂肪分布。
BMI 和非典型平衡可预测 CBT-SAD 治疗后两个冬季抑郁缓解的可能性更高,但不能预测 LT 治疗后的缓解情况。这项工作为临床决策和精准医学提供了信息。